ARCHIVES

Expanded Tissue Resources, Equipment Funds Planned.

This article is from The Cancer Letter archive.

Vol. 26 No. 45 | December 8, 2000

Download PDF Visit The Full Archive

Related Articles

Some NCAB Members Lack Understanding f Bypass Budget’s Value, Purpose

September 1, 1989

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984

BSA Working Group

November 12, 2010

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

January 4, 1991